Total Funding
26
71
Total FundingVenture - Series Unknown raised
Growth Score
-37 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
79612
IRIS preventative screening for Diabetic Retinopathy is as simple and quick as taking a patient's blood pressure or stepping on a scale.
Acquired by 
Topcon Healthcare
Steve Martin: Chief Executive Officer
Sunil Gupta: Founder, Chairman and Chief Medical Officer
Topcon Healthcare
About the Company
IRIS preventative screening for Diabetic Retinopathy is as simple and quick as taking a patient's blood pressure or stepping on a scale, and can be just as helpful to physicians in helping to detect eye disease or other disorders. The retina is a window into the body. Minute changes in the blood vessels of the retina can be early indicators of
issues elsewhere.
